X

HAPPENINGS

October 5, 2017 – Solving for x: A Solution to the Healthcare Conundrum? Healthcare Technology, Managed Care, and the Pharmaceutical Industry

  • FACT:  The US spends more per capita for healthcare than any other industrialized country.
  • FACT: The US is the only major industrialized country that does not provide healthcare coverage for all.
  • AT ISSUE: With all the money we spend on healthcare, why can’t we cover everyone for healthcare?

In today’s extremely contentious environment around how to fix healthcare, and the over-the-top frenzy surrounding getting something passed through congress, it might be worthwhile to step back and take a look at exactly what we are trying to “fix.” Let’s review an economic risk management framework that can fundamentally address the question of how much will healthcare cost, showing what levers are available to reduce costs, and a path forward to creating a more sustainable healthcare delivery model that we can all afford. We’ll touch on how healthcare technology, managed care and the pharmaceutical industry can participate to make this model successful. Please note that this is will not be a policy or political discussion.

About the speaker

Wayne Pan is a health economist, US Medical Affairs at Genentech, a global biotechnology company based in South San Francisco, and a member of the Roche Group. He has more than 20 years of healthcare industry experience from clinical medicine, to managed care, health information technology, and biotechnology. After 5 years of clinical practice as a fellowship-trained orthopaedic hand surgeon, Wayne served as the Chief Medical Officer (CMO) for several San Francisco Bay Area Medicaid managed care plans, helped start up two Medicare Advantage Dual Eligible Special Needs Plans, served as CMO of two San Francisco Bay Area IPAs (Affinity Medical Group, Santa Clara County IPA), as the CMO/Chief Medical Informatics Officer (CMIO) for three San Francisco Bay Area healthcare information technology start-ups, and as Advisory CMO for two healthcare “big data” analytics start-ups. Wayne currently serves on the Board of Directors for Semler Scientific, Inc. (SMLR:OTC), which has a patented non-invasive diagnostic device for early detection of peripheral vascular disease. He has also served as an Adjunct Assistant Professor of Marketing at the Wharton School, University of Pennsylvania.

Wayne completed his BA in Biology at Johns Hopkins University, his MD/PhD degrees concurrently at the Icahn School of Medicine at Mt. Sinai of New York University, and his MBA at The Wharton School, University of Pennsylvania. He did his residency in Orthopaedic Surgery at Thomas Jefferson University Hospital and Clinics, and a fellowship in hand and microsurgery at the Philadelphia Hand Center. Wayne also completed a post-graduate fellowship in Design at the California College of the Arts.

Images are licensed under Creative Commons License.

Leave a reply

Your email address will not be published. Required fields are marked *